Photo: marketwatch.com

Three founders of a company manufacturing ventilators have amasses a combined USD$7 billion (S$10 billion) to their wealth this year amid the unfolding impact of COVID-19 pandemic.
Driven by a spike in demand for the ventilators, the shares of Shenzhen Mindray Bio-Medical Electronics Co have risen 40 per cent. There has been a flood of patients brought by the pandemic, many are struggling to breathe.
The net worth of Chairman Li Xiting, a Singapore citizen and the city-state’s richest man has increased USD$3.5 billion (S$5 billion) in 2020 with a USD$12.5 billion (S$17.93 billion) wealth as of the end of Thursday, based on Bloomberg’s Billionaires Index. Thus, this registers him as the top fiver gainers worldwide. The world’s richest person, Jezz Bezos, saw an increase by USD$3.4 billion (S$4.88 billion) whereas Bill Gates saw a decrease of USD$15.3 billion (S$21.95 billion).
There is a shortage of ventilators amid the global health crisis, an equipment that is vital for treating the critically sick patients and keeping them alive. According to Mindray’s Board Secretary, Li Wenmei, with global demand at least 10 times the supply of ventilators at hospitals, other companies from General Motors to Ford Motor also rush in to increase production.
New York Governor, Andrew Cuomo said that in six days, there will be shortage of ventilators.
Infection numbers have topped one million whereas death toll globally is more than 52,000 individuals. The most impacted countries in Europe are Italy and Spain, but the pandemic is quickly spreading in the US as President Donald Trump cautioned of 100,000 or more mortality.
The US currently has around 200,000 ventilators but estimates by The Society of Critical Care Medicine suggest that 960,000 patients would be in need of ventilator support in the country. In Italy, which has the highest death toll, doctors have been forced to triage patients due to the chronic shortage of ventilators.
Until late March, the Food and Drug Administration (FDA) in the US authorised the use of Mindray’s ventilators in the current emergency to overcome the shortage. This is despite Mindray’s ventilators not having approvals in the US market. Thus, Mindray’s prospect has improved.
Analysts led by Tian Jiaqiang at Citic Securities Co. stated in a research note this week that the authorisation is “providing opportunities for Chinese ventilator products to enter the US market quickly”.
With over 3,000 ventilators output per month, Mindray is not the only manufacturer in China. Last month, FDA also authorised machines by Beijing Aeonmed Co, as stated on FDA’s website. Another manufacturer, Jiangsu Yuyue Medical Equipment & Supply Co has seen its shares increasing 91 per cent in 2020 in Shenzhen, increasing its market value to US$5.5 billion (S$ 7.90 billion).

Not without competition

According to Bloomberg Intelligence analyst Nikkie Lu, Mindray, which has USD$44 billion (S$63.18 billion) market capitalisation, still has the potential to expand its market share although it is not comparable in size to medical device titans such as Dublin-based Medtronic. She added that due Mindray’s products are able to enter Hong Kong and European markets and they have very good track records.
Mindray stated in an earnings filing this week that there was a dramatic increase in orders particularly from Europe, with Italy’s first batch order of close to 10,000 pieces of equipment including monitors and ventilators.
With presence in 30 countries and 17 subsidiaries in China, Mindray manufactures anaesthesia machines and infusion systems, health monitoring systems, defibrillators as well as ventilators. Based on its annual report, the company has a direct sales team in the US in addition to long-time global partners such as Cleveland Clinic, Mayo Clinic, Massachusetts General Hospital and Johns Hopkins Hospital.

Ventilator boom will not continue indefinitely

While there was spike in wealth of Mindary Chairman Li, his peers in Asia also experienced declines in net worth. Along with Xu Hang and Cheng Minghe, Mr Li founded the company in 1991.
Struggling with recession brought by the pandemic and political demonstrations last year, Hong Kong’s richest man, Li Ka Shing, lost USD$7.1 billion (S$10.18 billion) in 2020.
As for Singapore, it experienced the largest economic contraction in 10 years in Q1, and a severe recession is expected to be on the way for this year.
Ms Lu opined that the ventilator boom will not continue indefinitely. Demand for breathing-support equipment will increase as more societies age, but not to the extent that the pandemic brings about: “Sales will definitely drop after the outbreak.”

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

RCs in Bukit Batok SMC putting up and taking down PAP candidate's banner

The Online Citizen (TOC) was alerted by one reader on 27 April…

王乙康:“两次犯错才开除” 不应成为标准处理方式

针对近几日闹得沸沸扬扬的国大偷拍风波,我国教育部长在昨晚首次针对此事发文,强队对于危机校园学生的犯罪行为,都应采取强硬立场,向所有人发出强烈的讯息。 他在脸书贴文中表示,已先后向国大校长和国大董事部主席,表达对此事件的关注,同时也向他们指出,国大对涉及此事件的男生所采取的处分“明显不足”。 他认为“两次犯错才开除”,不应成为标准处理方式。“国大应该确保所有学生在校园内的安全,特别是女学生。” 他表示,国大将立即检讨该校的纪律和惩处框架,“我有信心国大检讨后能带来更严谨的纪律框架,国大董事会和校长正在处理这件事,他们有决心要停止校园内这类不可接受的行为。” 国大是在较早前受询时说,违规学生若重犯,将会被该校开除。“由于我们是教育机构,希望给学生机会,所以初犯者在纪律委员会上可能面对不同的处分,但不会直接被开除。” 23岁的受害者,国大女学生马芸(Monica Baey)早前Instagram公布她曾于去年11月,在校园宿舍洗澡时,遭到一名24岁男同学偷拍的经历。她表示,警方已经给予男生12个月的严厉警告,国立大学也要求男生写道歉信,并且停课一学期,禁止他进入大学大厅和宿舍,更为他提供辅导。 她在帖子中提到,她希望“犯下这种行为的肇事者接受真正的后果”,她认为男生受到的惩处太轻了。    

Human Rights Watch – Singapore: Yale to Curtail Rights on New Campus

PRESS RELEASE University Defends Agreement to Ban Protests and Political Party Groups…

“Singapore upholds free speech” – MM Lee’s press secretary

Foreigners have no right to engage in S’pore politics, she says.